タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
xAggregation and 14C-arachidonic acid (AA) metabolism of rabbit platelets were studied before and after intravenous injection of a selective thromboxane (TX) synthetase inhibitor, OKY-1581 (1-3mg/kg). Platelet aggregation induced by threshold concentrations of collagen and AA was inhibited for at least 3hr after the injection, but ADP-induced aggregation was not. The inhibitory effect of OKY-1581 injection on platelet TX synthetase was demonstrated by thin-layer radiochromatographic quantitation of lipid products obtained by incubating 14C-AA with washed platelets prepared after the injection: decreased production of TXB2 and hydroxyheptadecatrienoic acid associated with increased prostaglandin H2. When platelet-rich plasma (PRP) was preincubated in aggregometer cuvettes at 37°C or 7min with a rat aortic ring whose cyclo-oxygenase had been inhibited by aspirin injection, ADP-induced aggregation was inhibited in PRP prepared after the injection. This inhibitory effect of the aorta was hardly observed when platelet cyclo-oxygenase had been inhibited by indomethacin. When PRP prepared before the injection was employed, 2 aortic rings were necessary to inhibit platelet aggregation. These results suggested that ADP-induced aggregation was inhibited by prostacyclin which had been generated from platelet-derived prostaglandin endoperoxides by the cyclo-oxygenase-inhibited aortic ring and that the inhibition of platelet TX synthetase by OKY-1581 injection enhanced ex vivo prostacyclin production by the aorta in PRP.
- 一般社団法人 日本血栓止血学会の論文
一般社団法人 日本血栓止血学会 | 論文
- 日本人のＡＤＡＭＴＳ１３
- Infection of specific strains of Streptococcus mutans exacerbated intracerebral hemorrhage
- Transcriptional regulation of megakaryopoiesis and thrombopoiesis
- 新規血小板活性化受容体ＣＬＥＣ－２ その発見から今後の展望まで:その発見から今後の展望まで
- １．臨床血栓止血学オーバービュー